In vitro schedule-dependent interaction between paclitaxel and SN-38 (the active metabolite of irinotecan) in human carcinoma cell lines Yasuhiko KanoMiyuki AkutsuKen-Ichi Adachi ORIGINAL ARTICLE Pages: 91 - 98
Clinical pharmacokinetics of intravenous treosulfan in patients with advanced solid tumors Ralf Axel HilgerAndreas HarstrickMax Ernst Scheulen ORIGINAL ARTICLE Pages: 99 - 104
Molecular characterization of human acute leukemia cell line resistant to ZD9331, a non-polyglutamatable thymidylate synthase inhibitor Hiroyuki KobayashiYuzuru TakemuraHayato Miyachi ORIGINAL ARTICLE Pages: 105 - 110
Phase I and pharmacokinetic study of d-limonene in patients with advanced cancer David M. VigushinGrace K. PoonCancer Research Campaign Phase I/II Clinical Trials Committee ORIGINAL ARTICLE Pages: 111 - 117
Increased 9-aminocamptothecin dose requirements in patients on anticonvulsants Stuart A. GrossmanFred HochbergNABTT CNS Consortium ORIGINAL ARTICLE Pages: 118 - 126
Phase I study of E7010 Kaichiro YamamotoKiichiro NodaHisanobu Niitani ORIGINAL ARTICLE Pages: 127 - 134
Time dependency of hematopoietic growth factor coupled to chronotoxicity of carboplatin Ilan G. RonLeah PelegIsrael E. Ashkenazi ORIGINAL ARTICLE Pages: 135 - 141
Phase I study of oral JM216 given twice daily P. BealeF. RaynaudI. Judson ORIGINAL ARTICLE Pages: 142 - 148
Analytical and biological inequivalence of two commercial formulations of the antitumor agent bleomycin Robert T. DorrRoss MeyersJames D. Liddil ORIGINAL ARTICLE Pages: 149 - 154
Evaluation of the linearity of docetaxel pharmacokinetics Howard L. McLeodChristine M. KearnsRene Bruno ORIGINAL ARTICLE Pages: 155 - 159
Renal toxicity of the anticancer drug fostriecin Robert S. de JongElisabeth G. E. de VriesNanno H. Mulder ORIGINAL ARTICLE Pages: 160 - 164
Comparison of the pharmacokinetics and efficacy of irinotecan after administration by the intravenous versus intraperitoneal route in mice Sylvie GuichardEtienne ChatelutPierre Canal ORIGINAL ARTICLE Pages: 165 - 170
Glucocorticoid pretreatment reduces the cytotoxic effects of a variety of DNA-damaging agents on rat tibial growth-plate chondrocytes in vitro Helen RobsonElizabeth AndersonStephen Shalet SHORT COMMUNICATION Pages: 171 - 176